Deutsche Bank Aktiengesellschaft Issues Positive Forecast for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its price objective upped by Deutsche Bank Aktiengesellschaft from $120.00 to $128.00 in a research report released on Thursday morning,Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. JPMorgan Chase & Co. reduced their target price on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a report on Wednesday. Jefferies Financial Group set a $108.00 price objective on HealthEquity in a research note on Thursday, February 19th. BTIG Research dropped their target price on HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. Finally, UBS Group set a $110.00 price target on HealthEquity in a research note on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $110.36.

HealthEquity Stock Up 2.0%

HealthEquity stock opened at $81.13 on Thursday. The stock’s fifty day simple moving average is $80.59 and its 200-day simple moving average is $90.13. The company has a current ratio of 3.27, a quick ratio of 4.13 and a debt-to-equity ratio of 0.45. HealthEquity has a twelve month low of $72.76 and a twelve month high of $116.65. The firm has a market capitalization of $6.85 billion, a P/E ratio of 32.98, a P/E/G ratio of 0.99 and a beta of 0.26.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The firm had revenue of $334.59 million for the quarter, compared to analysts’ expectations of $332.48 million. The business’s revenue for the quarter was up 7.3% on a year-over-year basis. As a group, equities analysts expect that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Institutional Trading of HealthEquity

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Xponance Inc. grew its position in shares of HealthEquity by 0.8% in the third quarter. Xponance Inc. now owns 12,265 shares of the company’s stock valued at $1,162,000 after purchasing an additional 102 shares during the period. Advisors Asset Management Inc. grew its holdings in HealthEquity by 4.7% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company’s stock valued at $255,000 after buying an additional 110 shares during the period. Truist Financial Corp grew its holdings in HealthEquity by 4.9% in the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after buying an additional 119 shares during the period. Fiduciary Trust Co lifted its holdings in shares of HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares during the period. Finally, Larson Financial Group LLC lifted its holdings in shares of HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after acquiring an additional 123 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity News Summary

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Deutsche Bank raised its price target to $128 and kept a “buy” rating — the new target implies ~57.8% upside from the current price, signaling strong analyst conviction. Deutsche Bank price target raise
• Positive Sentiment: Q4 2026 results and call highlighted record HSA growth, revenue and EPS beats (quarterly revenue and EPS modestly ahead of consensus), supporting continued top-line momentum and cash economics. HQY Q4 2026 Earnings Call Highlights
• Positive Sentiment: Seeking Alpha published a rating upgrade citing improved cash economics, which reinforces buy-side theses around margin expansion and free cash flow improvement. Seeking Alpha upgrade
• Positive Sentiment: Press roundup / analyst commentary piece flagged HealthEquity among bullish healthcare names, adding to positive market narrative. Globe & Mail analyst roundup
• Neutral Sentiment: Full Q4 earnings call transcripts were posted across outlets (MSN, Seeking Alpha, Yahoo) — useful for digging into management commentary on enrollment, revenue cadence and margin drivers but not new information beyond the released results. MSN earnings transcript Seeking Alpha earnings transcript
• Negative Sentiment: Barrington Research trimmed its price target from $125 to $110 (still “outperform”), reducing upside assumptions to ~35.6% and signaling slightly less bullishness from one coverage shop. Barrington price target update
• Negative Sentiment: JPMorgan lowered its target from $129 to $123 but maintained an “overweight” rating, trimming some upside expectations while staying constructive (~51.6% implied upside). JPMorgan price target update
• Negative Sentiment: RBC cut its target from $110 to $100 (still “outperform”), tightening the analyst target band and signaling a more cautious near-term view. RBC price target update

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.